Top compounds associated with response to TRIM16L


Feature Type Standardized
Nominal ANOVA
mRNA linifanib CTRPv2 pan-cancer AAC 0.021 0.6
mRNA Irinotecan gCSI pan-cancer AAC -0.033 0.6
mRNA momelotinib CTRPv2 pan-cancer AAC 0.02 0.6
mRNA CID-5951923 CTRPv2 pan-cancer AAC 0.021 0.6
mRNA etomoxir CTRPv2 pan-cancer AAC -0.021 0.6
mRNA Erlotinib UHNBreast pan-cancer AAC 0.15 0.6
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.018 0.6
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.019 0.6
mRNA BRD-K66453893 CTRPv2 pan-cancer AAC -0.017 0.6
mRNA Bexarotene CTRPv2 pan-cancer AAC -0.019 0.6
Download CSV